Development Status

The drugs and devices from our portfolio companies follow a clear development path from discovery to approval.

Current Therapeutics Development Status

Discovery
Pre-Ind
IND
Phase 1
Phase 2
Phase 3
Actuate 9-ING-41
Azitra ATR-12
Azitra ATR-04
Cognition Therapeutics CT-1812
Encore Vision EV-06
Immusoft MPSI
Immusoft MPSII
IN8bio INAB-100
IN8bio INAB-200
N8bio INAB-400
Lantern Pharma LP-300
Lantern Pharma LP-184
Lantern Pharma LP-284
Lung Therapeutics LTI-01
Lung Therapeutics LTI-03
ONL Therapeutics ONL1204
Opus Genetics OPGx-001
Opus Genetics OPGx-002
SIRPant SIRPant-M
Stream Therapeutics PDV
Trefoil Therapeutics TTHX1114

Current Devices Development Status

Development
FDA Approval
Commercial
410 Medical Lifeflow with fluids
410 Medical Lifeflow with blood
i-Lumen Scientific 
Top